Actively Recruiting

Phase Not Applicable
Age: 30Years - 60Years
All Genders
Healthy Volunteers
ID07187297

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage FLX Radiofrequency Treatment to Improve Lines and Wrinkles and to Lift and Tighten Lax Tissue in the Neck, Abdomen, Upper Arms, and Face

Led by Bausch Health Americas, Inc. · Updated on 2025-12-17

164

Participants Needed

1

Research Sites

39 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate the safety and effectiveness of the Thermage FLX System, a device designed to improve lines and wrinkles and lift and tighten loose skin in adults aged 30 to 60 years. The study is a prospective, randomized, multicenter trial conducted at approximately 10 sites in North America and China. It focuses on mild-to-moderate skin laxity and wrinkles on the neck, abdomen, upper arms, and face. Participants are randomly assigned to receive treatment with the Thermage FLX device either on day 1 or day 90. The study compares treated participants with an untreated control group to assess improvements in skin appearance. The treatment involves a non-invasive radiofrequency procedure designed for dermatological use. During the 6-month (26-week) study, participants will attend scheduled visits for assessments by independent blinded evaluators. Researchers will measure the primary outcome at 90 days and secondary outcomes at 180 days after treatment. Safety, tolerability, and skin improvements will be closely monitored through various clinical evaluations and participant follow-up throughout the study period.

CONDITIONS

Brief Title

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

Who Can Participate

Age: 30Years - 60Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Be an adult female or male, aged 30 to 60 years
  • Have mild-to-moderate skin laxity or lines and wrinkles of the neck, abdomen, upper arms, and/or face as defined by specific rating scales
  • Females of childbearing potential must have a negative urine pregnancy test
  • Females of childbearing potential must agree to use an acceptable method of birth control during the study
  • Have no clinically abnormal findings based on medical history
  • Be able to follow study instructions, attend required visits, and complete all assessments
  • Understand the research nature of the study and sign informed consent
  • Agree to avoid energy-based device treatments, injectables, or plastic surgery on study areas during the study
  • Have a body mass index (BMI) of 30 or less
Not Eligible

You will not qualify if you...

  • Pregnant, breastfeeding, or trying to become pregnant within 3 months prior to screening or during the study
  • Given birth within 3 months prior to screening
  • Anticipated need for procedures, surgery, hospitalization, or events preventing required visits
  • Have a pacemaker, internal defibrillator, or other implanted electronic device
  • Have an implant in the target treatment zones
  • Have had radiation therapy in target treatment zones
  • Had prior cosmetic procedures in target zones within specified timeframes including Thermage, energy-based devices, derm abrasion, chemical peels, neurotoxins, fillers, or plastic surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Implementation

Duration - Up to 180 days

Participants receive treatment with the Thermage FLX device to improve skin laxity and reduce lines and wrinkles in target areas.

1 visit for treatment at day 1 or day 90 depending on group assignment and follow-up visits

Long-term Monitoring

Duration - Up to 180 days

Participants are monitored for safety and effectiveness of the Thermage FLX treatment over time.

Follow-up visits to assess outcomes up to 180 days post-treatment

Trial Site Locations

Total: 1 location

1

Union Square Laser Dermatology

New York, New York, United States, 10003

Actively Recruiting

Loading map...

Research Team

S

Sandra Narain

C

Caitlin Little

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Evaluation of the 2910 nm Erbium-Doped Fluoride Fiber Glass ...

Photodamaged Skin

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here